A patient with antisynthetase syndrome with pulmonary and muscular involvement was treated with immunosuppressive agents without corticosteroids. Rituximab was added to mycophenolate mofetil therapy with improvement in lung functional and imaging findings and normalization of creatine kinase levels.
CITATION STYLE
Sieradzka, A. E., Naccini, B., & Fontana, M. (2022). A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids. European Journal of Case Reports in Internal Medicine, 9(8). https://doi.org/10.12890/2022_003324
Mendeley helps you to discover research relevant for your work.